Step 1 topics → Renal → Acute Interstitial Nephritis (AIN)

Acute Interstitial Nephritis (AIN)

USMLE Step 1 trap: Assumes the classic AIN triad is reliably present rather than rarely complete. The full triad is present in fewer than 10–15% of AIN cases, so its absence does not exclude the diagnosis.

Acute Interstitial Nephritis (AIN) is an inflammatory condition of the renal interstitium — not the glomeruli — characterized by edema and a mononuclear cell infiltrate (often with eosinophils) that causes acute kidney injury. The classic teaching is a hypersensitivity reaction to a drug, and the prototype culprits are beta-lactam antibiotics, NSAIDs, PPIs, and sulfonamides. On USMLE Step 1, this topic shows up in vignettes where a patient develops AKI days to weeks after starting a new medication, and you need to identify the diagnosis, interpret supporting labs, and know the right management sequence.

The exam tests AIN from multiple angles: recognizing the classic (but rarely complete) triad, interpreting urinalysis findings like WBC casts and eosinophiluria, distinguishing NSAID-induced AIN from the allergic variety, and knowing what to do first when you suspect it. Where students get tripped up is over-relying on the triad — if you expect fever + rash + eosinophilia to all be present, you'll miss the diagnosis in the majority of real cases. The other major trap is treating eosinophiluria as a lock on the diagnosis when it's actually neither sensitive nor specific.

NSAID-induced AIN is its own beast and a favorite USMLE Step 1 distinction: it usually lacks the allergic triad entirely and often co-presents with nephrotic-range proteinuria from concurrent minimal change disease. If a vignette describes someone on chronic NSAIDs with AKI plus heavy proteinuria but no rash or fever, that combination should immediately signal NSAID-induced AIN. Getting the management order right also matters — drug removal comes before steroids, not after.

From real student decks
89%have cards covering this topic
81%have mature cards
1median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: The classic AIN triad (fever, rash, eosinophilia) is present in most cases.
Right: The full triad is present in fewer than 10–15% of AIN cases, so its absence does not exclude the diagnosis.
The triad of fever, rash, and eosinophilia is memorable precisely because it's taught as 'classic,' but it's present in fewer than 10–15% of cases — meaning its absence tells you almost nothing. If you use 'no rash, no AIN' as a mental shortcut, you will mismanage most real presentations. The diagnosis should stay on your differential whenever AKI follows a new drug exposure, even without a single triad element.
Common mistake
Wrong: Eosinophiluria is pathognomonic for AIN.
Right: Eosinophiluria has poor sensitivity and specificity for AIN and can occur in other conditions such as prostatitis and atheroembolic disease.
Eosinophiluria sounds like a slam-dunk finding for AIN, but it has poor sensitivity (misses many AIN cases) and poor specificity (appears in prostatitis, atheroembolic disease, and other conditions). Relying on its presence to confirm AIN or its absence to exclude AIN will lead you astray. Think of it as a weak supporting clue at best, not a diagnostic anchor.
Common mistake
Wrong: NSAID-induced AIN presents with the same allergic triad as penicillin-induced AIN.
Right: NSAID-induced AIN typically lacks the allergic triad and often presents with nephrotic-range proteinuria due to concurrent minimal change disease.
NSAIDs cause AIN through a different mechanism than penicillins — it's not the same IgE-mediated hypersensitivity, which is why the allergic triad is typically absent. More importantly, NSAIDs can simultaneously damage the glomeruli via minimal change disease, producing nephrotic-range proteinuria on top of the AKI. If you see that combination in a vignette, the NSAID-AIN pattern should jump out; don't expect the allergic features that would appear with a beta-lactam.
Common mistake
Wrong: Steroids are always required to treat AIN.
Right: The first and most important step is removing the offending agent; steroids are reserved for cases that fail to improve after drug discontinuation.
Steroids are not the first move — stopping the offending drug is. Many patients will recover kidney function with drug discontinuation alone, and initiating steroids before giving that a chance exposes the patient to unnecessary immunosuppression. Steroids become appropriate when the AKI fails to improve after withdrawal of the causative agent, or in severe/biopsy-confirmed cases where faster recovery is needed.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the classic AIN presentation including the fever-rash-eosinophilia triad, understand the typical timeline from drug exposure to symptom onset, and correctly interpret urinalysis findings (WBC casts, eosinophiluria, sterile pyuria) in this context.
  2. Identify the major drug and non-drug causes of AIN — including beta-lactams, NSAIDs, PPIs, sulfonamides, rifampin, and infectious/autoimmune causes — and distinguish which drugs tend to produce which presentation patterns.
  3. Apply the correct management sequence for AIN: recognize that removing the offending agent is the first and most critical step, and that corticosteroids are a second-line option reserved for cases that do not improve after drug discontinuation.

Can you avoid these mistakes?

A 55-year-old man started amoxicillin 2 weeks ago and now has AKI, low-grade fever, and urinalysis showing sterile pyuria and WBC casts. There is no rash and no peripheral eosinophilia. Does the absence of the full triad argue against AIN? What finding on urinalysis most specifically points toward interstitial rather than glomerular disease?
A 62-year-old woman on daily ibuprofen for arthritis develops AKI with urine protein of 4 g/day but no fever or rash. What diagnosis should you consider, and what additional glomerular pathology classically co-occurs with NSAID-induced AIN?
You suspect drug-induced AIN in a patient currently taking a PPI. Eosinophiluria is absent on urinalysis. How does this change your diagnostic thinking, and what is the most important first management step regardless of whether steroids will eventually be needed?
Rank the following in order of priority for a patient with suspected AIN: (a) start prednisone, (b) obtain renal biopsy, (c) discontinue the offending drug. Under what circumstance would you move option (a) earlier in the sequence?

Related topics

Kidney Development (Pro-/Meso-/Metanephros) Congenital Renal Anomalies Nephron Structure and Segments Renal Vasculature (Afferent / Efferent / Vasa Recta)

See how your Anki deck covers this topic.

Upload your deck for a free audit →